Venetoclax
About
Therapy type: Targeted therapy
Therapy strategy: BCL2 inhibition
Mappings
NCI Thesaurus: Venetoclax (coding:ncit:C103147)
RxNorm: venetoclax (coding:rxcui:1747556, coding:omop:35604205)
SNOMED: Venetoclax (coding:sctid:720491001, coding:omop:36717127)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) | TP53 Somatic variants | Chronic Lymphocytic Leukemia | Venetoclax | |
| EMA (1) | TP53 deletion | Chronic Lymphocytic Leukemia | Venetoclax | |
| EMA (2) | not 17p deletion | Chronic Lymphocytic Leukemia | Venetoclax | |
| EMA (1) | Wild type TP53 | Chronic Lymphocytic Leukemia | Venetoclax |